Results 101 to 110 of about 3,825,660 (342)

INTERVALOS DE CONFIANZA PARA EL PARÁMETRO DE LA DISTRIBUCIÓN BINOMIAL INTERVALOS DE CONFIANZA PARA EL PARÁMETRO DE LA DISTRIBUCIÓN BINOMIAL

open access: yesRevista Colombiana de Estadística, 2001
La construcción de intervalos de confianza para la estimación del parámetro π, de la distribución binomial, es un problema importante en el trabajo estadístico aplicado.
Correa M. Juan, Sierra L. Esperanza
doaj  

Influence of Dystrophin Isoform Deficiency on Motor Development in Duchenne Muscular Dystrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In Duchenne muscular dystrophy (DMD), lack of the shorter dystrophin isoforms Dp140 and Dp71 is associated with increased central nervous system (CNS) involvement. We aimed to investigate how CNS involvement affects motor development in young DMD boys.
Mary Chesshyre   +152 more
wiley   +1 more source

Device-independent certification of desirable properties with a confidence interval

open access: yesFrontiers in Physics
In the development of quantum technologies, a reliable means for characterizing quantum devices, be it a measurement device, a state-preparation device, or a transformation device, is crucial.
Wan-Guan Chang   +8 more
doaj   +1 more source

HOW CONFIDENT IS THE CONFIDENCE INTERVAL.

open access: yesAnnals of Ibadan postgraduate medicine, 2023
No abstract.
openaire   +2 more sources

Active Seizures Predict Worse Instrumental Activities of Daily Living in Individuals With Normal Cognition and Dementia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Cognitive disorders are common in older persons with seizures (PWS). Cognitive disorders are often associated with impaired Instrumental Activities of Daily Living (IADLs). However, the effects of seizures on IADLs remain unexplored.
Ifrah Zawar   +5 more
wiley   +1 more source

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy